|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Avastin (Bevacizumab). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (1304)
Cases resulting in a serious event (1198)
Cases resulting in death (206)
Cases resulting in life threatening events (71)
Cases resulting in hospitalization (515)
Cases resulting in disability (26)
Cases resulting in other serious reactions (574)
Below is a sample of reports where side effects / adverse reactions may be related to Avastin (Bevacizumab). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Body Temperature Increased, Post Procedural Complication, Headache, Hydrocephalus, Meningitis, Cerebrospinal Fistula, Intracranial Hypotension
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 10 mg/kg
Indication: Glioblastoma Multiforme
Start date: 2007-04-13
Tarceva
Dosage: 200 mg
Indication: Glioblastoma Multiforme
Start date: 2007-04-13
Other drugs received by patient: Lexapro; Keppra; Decadron; Lipitor
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-31
Patient: female, weighing 90.0 kg (198.0 pounds)
Adverse reactions / side effects: Uveitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-31
Patient: male, weighing 43.8 kg (96.4 pounds)
Adverse reactions / side effects: Pain in Extremity, Pain, Headache, Hyperhidrosis, Visual Disturbance, Heart Rate Increased, Nervous System Disorder, Gait Disturbance, Mobility Decreased, Muscle Spasms
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Gemzar
Adverse event in 37 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31
Patient: 37 year old female
Adverse reactions / side effects: Myalgia
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Lovenox; Calcium
Adverse event in 70 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-31
Patient: 70 year old female, weighing 93.0 kg (204.6 pounds)
Adverse reactions / side effects: Endophthalmitis, Vitritis, Eye Inflammation
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Splenomegaly
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Abraxane
Adverse event in 55 year old female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-30
Patient: 55 year old female, weighing 154.3 kg (339.5 pounds)
Adverse reactions / side effects: Gingival Ulceration, Osteonecrosis
Suspect drug(s):
Avastin
Dosage: 15 mg/ml, unk
Indication: Breast Cancer Metastatic
Start date: 2007-04-15
Zometa
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Taxotere; Zofran
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: male, weighing 101.6 kg (223.5 pounds)
Adverse reactions / side effects: Idiopathic Thrombocytopenic Purpura
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-30
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Uveitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-30
Patient: male
Adverse reactions / side effects: Cardiac Tamponade, Pericardial Haemorrhage, Carotid Aneurysm Rupture
Adverse event resulted in: death
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Fluorouracil; Camptosar
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Hepatic Failure, Disease Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp
Dosage: 200 a?g, prn
Indication: Anaemia
Avastin
Dosage: 590 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Fluorouracil
Dosage: 1140 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-07-20
Fluorouracil
Dosage: 760 mg, unk
Start date: 2005-08-02
End date: 2005-08-03
Fluorouracil
Dosage: 1140 mg, unk
Start date: 2005-08-02
End date: 2005-08-04
Leucovorin
Dosage: 380 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-03
Oxaliplatin
Dosage: 160 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Hepatic Failure, Hepatic Cirrhosis
Adverse event resulted in: death
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Abraxane; Aranesp; Lortab; Aleve; Skelaxin; Prednisone
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Hepatic Failure, Hepatic Cirrhosis
Adverse event resulted in: death
Suspect drug(s):
Avastin
Dosage: unk, days 1+15
Indication: Breast Cancer Metastatic
Start date: 2006-12-20
End date: 2007-02-28
Avastin
Dosage: 15 mg/kg, q3w
Start date: 2007-03-14
Other drugs received by patient: Paclitaxel; Abraxane
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-29
Patient: male
Adverse reactions / side effects: Haemolytic Anaemia
Suspect drug(s):
Avastin
Indication: Colorectal Cancer Metastatic
Xeloda
Indication: Colorectal Cancer Metastatic
Adverse event in 87 year old female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-29
Patient: 87 year old female
Adverse reactions / side effects: Anterior Chamber Disorder, Visual Disturbance, Vitreous Disorder
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from Switzerland on 2007-10-26
Patient: female
Adverse reactions / side effects: Alveolitis, Dyspnoea, Cough, Pneumonitis
Suspect drug(s):
Avastin
Indication: Breast Cancer Metastatic
Doxorubicin HCL
Indication: Breast Cancer Metastatic
Other drugs received by patient: Netium; Netium
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: male
Adverse reactions / side effects: Drug Ineffective, Blindness
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Plavix; Zocor
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Coronary Artery Thrombosis, Pulmonary Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in 68 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-26
Patient: 68 year old female
Adverse reactions / side effects: Gastric Ulcer Haemorrhage, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-09-14
Paraplatin
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-10-10
Taxol
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-10-10
Other drugs received by patient: Durotep; Primperan; Kenalog; Novamin; Loxonin; Selbex; Adofeed; Oxynorm; Goshajinkigan; Senna Leaf; Oxycontin; Magmitt; Noritren; Laxoberon
Adverse event in 74 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-26
Patient: 74 year old female
Adverse reactions / side effects: Endophthalmitis, Vitritis, Anterior Chamber Inflammation, Eye Irritation
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient:
Adverse reactions / side effects: Cerebrovascular Accident
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in 89 year old female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 89 year old female
Adverse reactions / side effects: Hypertension
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-26
Patient: male
Adverse reactions / side effects: Pancytopenia, Septic Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Avastin
Dosage: 275 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Camptosar
Dosage: 300 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Fluorouracil
Dosage: 4600 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Folinic Acid
Indication: Drug USE FOR Unknown Indication
Start date: 2006-07-10
End date: 2006-07-10
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-26
Patient: male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Small Intestinal Obstruction, Neoplasm Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Folinic Acid; Fluorouracil; Oxaliplatin
|
